Showing 1621-1630 of 7031 results for "".
When to Consider Therapeutic Switching in Plaque Psoriasis: Best Practices for Nurse Practitioners, Physician Assistants, and Physicians
https://practicaldermatology.com/topics/psoriasis/when-to-consider-therapeutic-switching-in-plaque-psoriasis-best-practices-for-nurse-practitioners-physician-assistants-and-physicians/21054/What to know about patient experiences and the proper approaches to modifying treatment regimens.New Biologics
https://practicaldermatology.com/topics/psoriasis/new-biologics/18635/Craig Leonardi, MD, shares insight on developments in biologics that may offer significantly improved efficacy compared with existing agents. Dr. Leonardi also discusses the rapidly evolving treatment paradigm in the management of psoriasis.Superficial Radiation for Keloids: SRT-100 in Practice
https://practicaldermatology.com/topics/skin-cancer-photoprotection/superficial-radiation-for-keloids-srt-100-in-practice/19040/Keloids are common. Certain patients, especially patients of color, are more prone to the development of keloids in certain locations, especially areas such as the chest, back, and other areas. Most studies that show that keloids can occur in up to 90 percent of cases when they're excised. The use oBiologics and Pediatric Psoriasis
https://practicaldermatology.com/topics/practice-management/biologics-and-pediatric-psoriasis/21196/Though data has been lacking in recent years, the use of biologics in pediatric and adolescent patients deserves more consideration.Part 3: New Developments in Biologics
https://practicaldermatology.com/topics/psoriasis/part-3-new-developments-in-biologics/18965/In this edition of Derm Insider, host Neal Bhatia, MD tackles the evolving systemic treatment landscape for psoriasis with guests Alice Gottlieb, MD, Harold Farber, MD, and James Ulery, MD. In Part III, they discuss new developments in biologic therapy.Bellafill Fills a Niche; Soolantra Targets Rosacea
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-bellafill-fills-a-niche-soolantra-targets-rosacea-/18995/In this edition of DermWireTV from the editors of Practical Dermatology® magazine, a look at the approval of Bellafill (Suneva) to treat acne scars and Soolantra (Ivermectin 1%, Galderma) to treat rosacea. Plus, Benzac (Galderma) is now available OTC to treat acne, and Opdivo (Bristol-Myers Squibb)2014 Year in Review: Actinic Keratosis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/2014-year-in-review-actinic-keratosis/19003/Neal Bhatia, MD discusses the management of actinic keratosis in 2014. He also offers a look at what's ahead for the specialty as a whole in 2015.2014 Fourth Quarter Tax Saving Tips
https://practicaldermatology.com/topics/practice-management/2014-fourth-quarter-tax-saving-tips/21294/What to do now to save $10,000-$25,000 or more on your 2014 taxes.The Horizon of Aesthetic Treatments
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-horizon-of-aesthetic-treatments/19036/Dina Anderson, MD, FAAD, takes a look at the future of aesthetic procedures, particularly treatments for submental fat as well as the ocular area that may play a major role in shaping the spectrum of aesthetic procedures.The Evolution of Injectables
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/anderson-2--apolesod/19038/Dina Anderson, MD, FAAD, discusses the changing landscape of injectable agents and how patients are more informed about various products and procedures.